Text Box: Newsletter
Abreast Of  Ear, Nose & Throat / Head & Neck Advances
26,March,  2006
 
Hello, All. Welcome to this week's ORL Update.  I do hope you find the pick for this edition useful
 
Biodun Olusesi, Newsletter Editor
Transcanal PGE1 and Increased CBF.......?

The cochlear blood flow (CBF) , which in human is just about 0.0001% of the cardiac output, and known to be influenced by several pharmacological agents have been severally investigated for agents ranging from steroids, adrenergic agonists, adrenergic antagonists, vasodilators, Leukotrienes, among others. Recall a previous issue of the newsletter (Vol1No 5) where the paper reporting topical application to round window (RW) of rhodamine-encapsulated PLGA nanoparticles was reviewed. Another study recently (Mitsuo Tominaga et al, Acta Oto-Laryngologica, 2006; 126: 232 - 236) investigated the effect of topical application of PGE1 on CBF in experimental rats and guinea pigs and observed increase in CBF in both animals, with a presumption that if this result is validated in subsequent studies, selective PGE1 to RW may become useful in treatment of inner ear diseases.

Abstract: Conclusions. The increase in cochlear blood flow (CBF) after administration of prostaglandin E1 (PGE1) to the round window depends on increased blood flow through the anterior inferior cerebellar artery (AICA). Objectives. To evaluate the response of CBF to PGE1 applied topically to the round window, and to investigate the origin of blood flow changes after this topical application. Material and methods. The response of CBF to topically applied PGE1 was measured by placing the tip of a laser Doppler probe on the bony wall of the basal turn of the cochlea after the middle ear mucosa over the cochlea had been removed in guinea pigs and rats. In rats, the CBF response to PGE1 administration was investigated after occlusion of the AICA or stapedial artery. Results. CBF increased following PGE1 administration in both guinea pigs and rats. In rats, CBF increased from 100% to 132%9/10% (mean9/SD) after the topical application of 0.5 ml of a 0.014% PGE1 solution. CBF decreased after occlusion of the AICA or stapedial artery but did not increase after PGE1 administration during occlusion of the AICA. The CBF response to PGE1 administration was similar before and after occlusion of the stapedial artery.
 
TOP PICKS

PCA Defect and Sudden Deafness..?
A recent open access study (Tsushima, Taketomi-Takahashi & Endo, BMC Ear, Nose and Throat Disorders 2006, 6:5) designed to investigate the link between sudden deafness and defect of posterior communicating artery (PCA) failed to observe statistically significant link between the two.

Abstract: Background A strong association was suggested between a non-functioning posterior communicating artery (Pcom) of the circle of Willis and sudden deafness (SD). The purpose of this study was to determine the rate of depiction of the posterior communicating artery (Pcom) on magnetic resonance angiography (MRA) in patients with SD. Methods Sixteen patients with SD (47.7 +/- 13.3 years; range, 24 - 76 years; nine males) were evaluated with intracranial MRA as well as magnetic resonance imaging (MRI) of the head. The depiction of Pcom on MRA was correlated with the laterality of SD. One hundred twenty-eight controls (49.1 +/- 8.4 years; range, 22 - 66 years; 87 male) were selected from neurologically normal subjects who underwent MR examinations as a part of an annual medical check-up in our hospital. Results Four (25%) of 16 SD patients had bilateral Pcom on MRA, four patients had unilateral Pcom and eight patients had bilaterally absent Pcom These results were not significantly different from the controls (p=0.96). In 6 (37.5 %) of 16 SD patients, the ipsilateral Pcom was present on MRA, and 104 (40.6%) of 256 Pcom were present in 128 normal controls (p=0.81). Conclusions Since there was no link between the occurrence of SD and the absence of the ipsilateral Pcom, our results cannot support the hypothesis that the absence of Pcom may be a risk factor for the occurrence of SD.


Coming Events of Importance to Otolaryngologists in Africa...
 

  1. 8th International Otology Course of the Jean Causse Ear Clinic
    June 22-24, 2006; Béziers, France
  2. 110th American Academy of ORL,Head & Neck Surgery Annual Meeting & OTO EXPO
    September 17-20, 2006;
    Toronto, Canada.
  3. 42nd South African ENT Congress joint meeting with the British Association of Otolaryngology - Head & Neck Surgery
    October 29-November 1, 2006;
    Cape Town, South Africa.

         For more Worldwide otolaryngological events and conferences....Click Here


Dextran 40 & SD in Pregnancy....?       

The recognized risks of  iv Dextran therapy (coagulopathy, renal failure and non-cardiogenic pulmonary oedema) as well as  the known riskt of steroid therapy on the pregnant female as well as the fetus puts the otolaryngologist at a crossroad when faced with management of sudden deafness (SD) in pregnancy. A new study from Taiwan (Yen-Ping Wang & Yi-Ho Young, Acta Oto-Laryngologica, 2006; 126: 271 -276) reported significant benefit of Dextran 40 in pregnant women with SD without adverse effect of the mother or fetus

Abstract: Conclusion. Excluding the possibility of acoustic neuroma, therapeutic benefits from dextran 40 can be anticipated in a pregnant woman with sudden deafness, leading to significant hearing improvement, without detrimental effect on the mother or fetus. Objective. The aim of this study was to present our experience in the treatment of pregnant women with sudden deafness during the past decade. Methods. From January 1994 to December 2003, 12 pregnant women with sudden deafness were consecutively encountered at the authors’ clinic. With the exception of one patient with acoustic neuroma who underwent craniotomy, six patients were treated with dextran 40 only, while the other five patients preferred no medication, and served as a control group. Each patient underwent audiometry before treatment and at 1 year postpartum. Results. In the dextran group, five (83%) of six patients had hearing improvement 1 year postpartum, compared with one (20%) of five patients in the control group showing hearing improvement; both groups revealed a significant difference. Those receiving intravenous dextran treatment had significant hearing improvement at the frequencies of 1000, 2000, and 4000 Hz, at 1 year postpartum. In contrast, in those who followed a natural course without medication no significant difference existed in the mean hearing level of each frequency, at 1 year after delivery.

Text Box: Previous Newsletter

 
Case Review
 
CLINICAL RADIOGRAPH  OF THE WEEK

A 55-year old male presented with reccurent excruciating right hemicranial headache worse in the right periorbital region of 4 months duration.  The onset was preceded by an attack of flu. There was little response to analgesia. Clinical and opthalmological examinations were negative.MRI brain was negative. CT Scan of sinuses revealed the feature shown (red outline). You may want to see other views for clarity..

 

What is the diagnosis?

  • Parting Shot...
    If you have an interesting case to discuss or share with other Otolaryngologists all over Africa, feel free to email Me or at best go to otolaryngology in Africa blogsite and post your case
  • Also, if you are among those who requested for a copy of DODA at the last ORLSON Meeting @ Port Harcourt, please take time to view the DODA - FAQ page, you should have received your copy by now. If you have difficulty on using the program, please text +2348032472069.
  • An online video demonstration of doda is available at http://www.otolaryngologyinafrica.net/doda_video.htm  This video takes about 30 - 45 minutes to fully load on a broad band network the first time, but once fully loaded could be viewed over and over again
  • If you have anything you want to communicate with other Otolaryngologists - news, request, etc, feel free to email your communication to orl-mailer@ otolaryngologyinafrica.net. Your request will appear in member's page soon to be created.
  • Reviewers wanted for otolaryngology news journals watch page. If you are an Otolaryngologist in Africa and will like to be our journal reviewer, please feel free to email orl-mailer@otolaryngologyinafrica.net
  • DODA 2006, capable of advanced hearing measure, and also paediatric hearing assessment is being developed. If you requested for and got a free copy of DODA, you may also look out for this latest version dubbed DODA 2006, as well as for an additional page on outcome of hearing assessment using DODA.
  • Watch out for otolaryngological.net Journal Club Page!

Till Next Week,

Biodun


 

NEWSLETTER                    TOP                  PREVIOUS NEWSLETTER

This is a free email newsletter circulating to Otolaryngologists in Africa, and interested Otolaryngologists elsewhere. If you know anyone interested in receiving this free newsletter, feel free to forward a copy to such person or encourage them to email orl-mailer@otolaryngologyinafrica.net for subscription

© Copyright Dr 'Biodun Olusesi,  2005 - 2006

Embedded CGI removed by Open WebMail.
http://www.processrequest.com/apps/msgopen.asp?id=23671813,ZddihibaheEB&oid=UcjjbCB&taskid=WhjjfjjEI

 
Text Box: Vol.2, No.10, March, 2006

Text Box: Home